The role of trans fatty acids in human nutrition

Starch/Staerke

Volumn 52, Issue 6-7, 2000, Pages 229-235

  Hayakawa, Kyoko ^a   Linko, Yu Yen ^b   Linko, Pekka ^b  

^a Fukuoka Women's Junior College   (Japan)

^b AALTO UNIVERSITY   (Finland)

Author keywords

Blood cholesterol; Cancer; Coronary heart disease; Human nutrition; Trans fatty acids

Indexed keywords

EID: 0010043507     PISSN: 00389056     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-379X(200007)52:6/7<229::AID-STAR229>3.0.CO;2-G     Document Type: Article

References (89)

1. J. Fritsche, H. Steinhart: Analysis, occurrence, and physiological properties of trans fatty acids (TFA) with particular emphasis on conjugated linoleic acid isomers (CLA) - a review. Fett/Lipid 100 (1998) 190-210.
2. D. Kritschevsky: The effects of dietary trans fatty acids. Chem. & Ind. 1996/15 (1996) 565-567.
3. W. C. Willett, M. J. Stampfer, J. E. Manson, G. A. Colditz, F. E. Speizer, B. A. Rosner, I.A. Sampson, C. H. Hennekens: Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341 (1995) 581-585.
4. P. McKeigue: Trans fatty acids and coronary heart disease: weighing the evidence against hardened fat. Lancet 345 (1995) 269-270.
5. F. R. Senti: Health Aspects of Dietary Trans Fatty Acids. ISRD, Bethesda, Maryland 1985.
6. S. Stender, J. Dyerberg, G. Hølmer, L Ovesen, B. Sandström: The influence of trans fatty acids on health: A report from the Danish Nutrition Council. Clin. Sci. 88 (1995) 375-392.
7. The British Nutrition Foundation: Report of the The British Nutrition Foundation Task Force: 'Trans Fatty Acids'. The British Nutrition Foundation, London 1995.
8. E. B. Feldman, P. M. Kris-Etherton, D. Kritchevsky, A. H. Lichtenstein: ASCN/AIN Task Force on trans Fatty Acids; Position paper on trans fatty acids. Am. J. Clin. Nutr. 63 (1996) 663-670.
9. C. Alexandra, M. Jim, S. Wayne, D. Ashley, S. Murray, F. Christopher: Effect on lipoprotein profile of replacing butter with margarine in a low fat diet: randomised crossover study with hypercholesterolaemic subjects. British Med. J. 312 (1996) 931-934.
10. M. A. Belury: Conjugated dienoic linoleate: a polyunsaturated fatty acid with unique chemoterapeutic properties. Nutr. Rev. 53 (1995) 83-89.
11. S. Visonneau, A. Cesano, S. A. Tepper, J. A. Scimeca, D. Santoli, D. Kritschevsky: Conjugated linoleid acid suppresses the growth of human brest adenocarcinoma cells in SCID mice. Anticancer Res. 17 (1997) 969-974.
12. K. N. Lee, D. Kritschevsky, M. W. Pariza: Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108 (1994) 19-25.
13. A. Ascherio, C. H. Hennekens, J. E. Buring, C. Master, M. J. Stampfer, W. C. Willett: Trans fatty acid intake and risk of myocardial infarction. Circulation 89 (1994) 94-101.
14. H. B. W. Patterson: Hydrogenation of Fats and Oils: Theory and Practise. AOCS Press, Champaign, Illinois, 1994.
15. V. Fellner, F. D. Sauer, J. K. G. Kramer. Steady-state rates of linoleic acid biohydrogenation by ruminant bacteria in continuous culture. J. Dairy Sci. 78 (1995) 1815-1823.
16. J. Fritsche, R. Rickert, H. Steinhart, M. P. Yurawecz, M. M. Mossoba, N. Sehat, J. A. G. Roach, J. K. G. Kramer, Y. Ku: Conjugated linoleic acid (CLA) isomers: formation, analysis, amounts in foods, and dietary intake. Fett/Lipid 101 (1999) 272-276.
17. M. C. Craig-Schmidt: Fatty acid isomers in foods. In: Fatty Acids in Food and Their Health Implications Eds. C. K. Chow, Marcel Dekker, 1992, pp. 365-398, New York, USA.
18. J. H. Dickson: Report on the expert panel on trans fatty acids and coronary heart disease risk. Am. J. Clin. Nutr. 62 (1995), 655S-708S.
19. R. L. Wolff, D. Precht, J. Molkentin: Trans-18:1 acid content and profile in human milk lipids. Critical survey of data connection with analytical methods. J. Am. Oil Chem. Soc. 75 (1998) 661-671.
20. W. C. Willett, A. Ascherio: Trans fatty acids; are the effects only marginal? Am. J. Public Health. 84 (1994) 722-724.
21. D. Precht, J. Molkentin: Trans fatty acids:implications for health, analytical methods, incidence in edible fats and intake. Food-Nahrung 39 (1995) 343-374.
22. D. Firestone, A. Sheppard: Determination of trans fatty acids. Adv. Lipid Metabol. 1 (1992) 93-151.
23. A. Ascherio, M. B. Katan, O. L. Stock, M. J. Stampfer: Trans fatty acids and coronary heart disease. N. Eng. J. Med. 340 (1999) 1994-1998.
24. J. L. Sébédio, W. W. Christie: Trans Fatty Acids in Human Nutrition. Oily Press, Dundee (UK) 1998.
25. E. A. Emken: Do trans acids have adverse health consequences? In: Health Effect of Dietary Fatty acids. Ed. G. J. Nelson, American Oil Chemists' Society, Champaign (Illinois) 1991, pp. 245-263.
26. P. M. Kris-Etherton: Trans fatty acids and coronary heart disease risk: report of the expert panel on trans fatty acids and coronary heart disease. Am. J. Clin. Nutr. 62 (1995) 655S-708S.
27. R. Wood: Distribution of dietary geometrical and positional isomers in brain, heart, kidney, liver, lung, muscle, splean, adipose tissue and hepatoma. In: Geom. Positional Fatty Acid Isomers. Eds. E. A. Emken, H. J. Dutton, American Oil Chemists'Society, Champaign (Illinois) 1979, pp. 213-281.
28. A. C. Lanser, E. A. Emken, J. B. Ohlrogge: Oxidation of oleic and elaidic acids in rat and human heart homogenates. Biochim. Biophys. Acta 875 (1986) 510-515.
29. A. C. van Houwelingen, G. Hornstra: Trans fatty acids in early human development. In: Fatty Acid and Lipids: Biological Aspects. Eds. C. Galli, A. P. Simopoulos, E. Tremoli, World Rev. Nutr. Diet., Karger, Basel 75 (1994) 175-178.
30. B. Koletzko: Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Paediatr. 81 (1992) 302-306.
31. T. Decsi, B. Koletzko: Do trans fatty acids impair linoleic acid metabolism in children? Ann. Nutr. Metab. 39 (1995) 36-41.
32. D. Kirstein, C.-E. Høy, G. Hølmer: Effect of dietary fats on the Δ6- and Δ5-desaturation of fatty acids in rat liver microsomes. Br. J. Nutr. 50 (1983) 749-756.
33. H. W. Cook, E. A. Emken: Geometric and positional fatty acid isomers interact differently with desaturation and elongation of linoleic and linolenic acids in cultured glioma cells. Biochem. Cell Biol. 68 (1990) 653-660.
34. C.-E. Høy, G. Hølmer: Dietary linoleic acid and the fatty acid profiles in rats fed partially hydrogenated marine oils. Lipids 23 (1988) 973-980.
35. J. L. Zevenbergen, U. M. T. Houtsmuller, J. J. Gottenbos: Linoleic acid requirement of rats fed trans fatty acids. Lipids 23 (1988) 178-186.
36. O. Takahisa, K. Youko, K. Hiromu, N. Isao, S. Michihiro: Trans fatty acid contents of various foods cooked with oils and fats in Japan. Oil Chem. (in Japanese) 42 (1993) 996-1002.
37. J. Folch, M. Lees, G. H. S. Stanley: A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1967) 497-509.
38. G. E. Mary, A. Subodh, K. Mark, S. Joseph: Isomeric trans fatty acids in the US diet. J. Am. College Nutr. 9 (1990) 471-486.
39. D. B. Allison, S. K. Egan, L. M. Barraj, C. Caughman, J. F. Heinbach: Estimated intakes of trans and other fatty acids in the US population. J. Am. Diet. Assoc. 99(2) (1999) 166-174.
40. K. F. Hulshof, M. A. van Erp-Baart, M. Anttolainen, W. Becker, S. M. Church, C. Couet, E. Hermann-Konz, H. Kesteloot, T. Leth, I. Martins, O. Moschandreas, L. Pizzoferrato, A. H. Rimestad, H. Thorgeisdottir, I. M. van Amelsvoort, A. Aro, A. G. Kafatos, D. Lanzmann-Petithory,G. van Poppel: Intake of fatty acids in Western Europe with emphasis on trans fatty acids. Eur. J. Clin. Nutr. 53 (1999) 143-157.
41. J. Fritsche: Contents of trans fatty acids (TFA) in German foods and estimation of daily intake. Fett/Lipid 99 (1997) 314-318.
42. T. Okamoto, T. Tsutsumi, S. Tokairu, H. Ehara, T. Maruyama, I. Niiya, M. Sugeno: Formation of trans-fatty acids during vegetable oil refining and trans-fatty acid content in refined edible oils. Nihon Yukagakkaishi (in Japanese) 48 (1999) 877-883.
43. S. J. London, F. M. Sacks, J. Caesar, M. J. Hemton, E. N. Siguel, and W. C. Willett: Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am. J. Clin. Nutr. 54 (1991) 340-345.
44. H. T. Slover, R. H. Thompson, Jr., C. S. David, G. V. Merd: Lipids in margarines and margarine-like foods. J. Am.Oil. Chem. Soc. 62 (1985) 775-786.
45. A. Pfalzgraf, M. Timm, H. Steinhart: Amounts of trans fatty acids in foods. Z. Ernährungswiss. 33 (1994) 24-43.
46. S. Michihiro: Physiological function of unsaturated fatty acids. Food and Food Manufacture (in Japanese) 31 (1996) 9-12.
47. T. Okamoto: Nutritional research on hardening fish oil. Doctoral dissertation (in Japanese). Faculty of Agriculture, Kyushu University 1989.
48. H. Matsuzaki, C. Ota, Y. Kinoshita, T. Maruyama, I. Niiya, M. Sugano: Trans fatty acid content of margarines in Portugal, Belgium, Netherlands, United Kingdom, United States and Japan. J. Japan Oil Chem. Soc. 47 (1998) 195-199.
49. M. G. Enig: Trans fatty acids - an update. Nutr. Q. 17 (1993) 79-95.
50. J. Parterisa, R. Codoni, J. Boatella, M. Rafecas: Fatty acids including trans content of commercial bakery products manufactured in Spain. J. Agric. Food Chem. 47 (1999) 2040-2043.
51. [51 ] J. Fritsche, H. Steinhart: Trans fatty acid content in German margarines. Fett/Lipid 99 (1997) 214-217.
52. L. Ovesen, T. Leth, K. Hansen: Fatty acid composition of Danish margarines and shortenings, with special emphasis on trans fatty acids. Lipids 31 (1996) 971-975.
53. C. C. Bayard, R. L. Wolf: Trans 18:1 acids in French tub margarines and shortenings: Recent trends. J. Am. Oil Chem. Soc. 72 (1995) 1485-1489.
54. B. F. Haumann: Widening array of spreads awaits shoppers. INFORM 9 (1998) 6-13.
55. L. L. Kok, W. R. Fehr, E. G. Hammond, P. J. White: Transfree margarine from highly saturated soybean oil. J. Am. Oil Chem. Soc. 76 (1999) 1175-1181.
56. L. Z. Peter, B. K. Martijin: Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids lipoproteins in humans. J. Lipid Res. 33 (1992) 399-410.
57. T. Rebecca, C. W. Walter, T. W. Scott: Trans fatty acid intake in relation to serum lipid concentrations in adult men. Am. J. Clin. Nutr. 56 (1992) 1019-1024.
58. W. Randall, K. Karen, O. Barbara, T. Stephen, M. Gail: Effect of butter, mono- and polyunsaturated fatty acid - enriched butter, trans fatty acid margarine, and zero trans fatty acid margarine on serum lipids and lipoproteins in healthy men. J. Lipid Res. 34 (1993) 1-11.
59. R. P. Mensink, M. B. Katan: Effect of dietary trans fatty acids on high density and low density lipoprotein cholesterol in healthy subjects. New Engl. J. Med. 323 (1990) 439-445.
60. K. Almendingen, O. Jordal, P. Kirerulf, B. Sandstad, J. I. Pedersen: Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and LP (a) in men. J. Lipid Res. 36 (1995) 1370-1384.
61. P. H. Nestel, M. Noakes, B. B. Belling, R. McArthur, P. M. Clifton, M. Abbery: Plasma cholesterol-lowering potential of edible oil blends suitable for commercial use. Am. J. Clin. Nutr. 55 (1992) 46-50.
62. P. M. Ronald, B. K. Martijn: Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. New England J. Med. 323 (1990) 439-445.
63. R. Troisi, W. C. Willett, S. T. Weiss: Trans fatty acid intake in relation to serum lipid concentrations in adult men. Am. J. Clin. Nutr. 56 (1992) 1019-1024.
64. J. T. Judd, B. A. Clevidence, R. A. Muesing, J. Wittes, M. E. Sunkin, J. J. Podczasy: Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am. J. Clin. Nutr. 59 (1994) 861-969.
65. P. L. Zock, M. B. Katan: Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J. Lipid Res. 33 (1992) 399-410.
66. F. B. Hu, N. J. Stampfer, J. K. Manson, E. Rimm, G. A. Colditz, B. A. Rosner, C. H. Hennekens, W. C. Willett: Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 337 (1997) 491-499.
67. [67) Flair-Flow Europe: Health aspects of trans PUFAs. Flair-Flow Reports F-FE 285/98 1998.
68. R. P. Mensink, P. L. Zock, M. B. Katan, G. Hornstra: Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans. J. Lipid Res. 33 (1992) 1493-1501.
69. M. B. Katan, P. L. Zock, R. P. Mensink: Trans fatty acids and their effects on lipoproteins in humans. Ann. Rev. Nutr. 15 (1995) 473-493.
70. H. Heckers, M. Korner, T. W. L. Taschen, F. W. Melcher: Occurrence of individual trans-isomeric fatty acids in human myocardium, jejunum and aorta in relation to different degrees of atherosclerosis. Atherosclerosis 28 (1977) 389-398.
71. L. H. Thomas, J. A. Winter, R. G. Scott: Concentration of 18:1 and 16:1 transunsaturated fatty acids in the adipose body tissue of decendents dying of ischaemic heart disease compared with controls: analysis by gas liquid chromatography. J. Epidemiol. Com. Health 47 (1983) 16-21.
72. A. Aro, A. F. M. Kardinaal, I. Salminen, J. D. Kark, R. A. Riemersmam, M. Delgado-Rodriguez, J. Gomez-Aracena, J. K. Huttunen, L. Kohlmeier, B. C. Marin, J. M. Marin-Moreno, V. P. Mazaev, J. Ringstad, M. Thamm, P. van't Veer, F. J. Kok: Adipose tissue isomeric trans fatty acids and risk of myocardinal infarction in nine countries: the EURAMIC study. Lancet 345 (1995) 273-278.
73. T. L. Roberts, D. A. Wood, R. A. Riemersma, P. J. Gallagher, F. C. Lampe: Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet 345 (1995) 278-282.
74. J. Jiang, L. Björk, R. Fondén, M. Emanuelson: Occurrence of conjugated cis-9, trans-11-octadecadienoic acid in bovine milk: Effects of feed and dietary regimen. J. Dairy Sci. 79 (1996) 438-445.
75. G. Jahreis, J. Fritsche, H. Steinhart: Conjugated linoleic acid in milk fat: High variation depending on production system. Nutr. Res. 17 (1997) 1479-1484.
76. Y. L. Ha, J. Storkson, M. W. Pariza: Inhibition of benzo(a)-pyrene-induced mouse forestomach neoplasia by conjugaled derivatives of linoleic acid. Cancer Res. 50 (1990) 1097-1101.
77. C. Ip, C. Jiang, H. J. Thompson, J. A. Scimeca: Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. Carcinogenesis 18 (1997) 755-759.
78. WHO and FAO joint consultation: Fats and oils in human nutrition. Nutr. Reviews 53 (1995) 202-205.
79. Anonymous: Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Federal Register 64 FR 62745, November 17, 2000.
80. J. M. Jones: Dietary fiber: A factor in modulation of cardiovascular disease risk? Cereal Foods World 45 (2000) 25-27.
81. M. Olewnik: Trans fats: What's the big deal? Food Quality 7(1) (2000) 35.
82. M. Noakes, P. M. Clifton: Oil blends containing partially hydrogenated or interesterified fats: differential effects on plasmalipids. Am. J. Clin. Nutr. 68 (1998) 242-247.
83. J. T. Judd, D. J. Baer, B. A. Clevidence, R. A. Muesing, S. C. Chen, J. A. Westrate, G. W. Meijer, J. Wittes, A.-H. Lichtenstein, M. Vilella-bach, E. J. Shaefer: Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in normolipemic adults fed controlled diets. Am.J. Clin. Nutr. 68 (1998) 768-777.
84. International Society for the Study of Fatty Acids and Lipids (ISSFAL): NEWSLETTER. Ed. A. A Spector 3 (1996) 1-10.
85. T. Byers: Hardened fats, hardened arteries. N. Eng. J. Med. 337 (1997) 544-545.
86. P. H. Abelson: A third technological revolution. Science 279 (1998) 2019.
87. W. M. Willis, R. W. Lencki, A. G. Marangont: Lipid modification strategies in the production of nutritionally functional fats and oils. Crit. Rev. Food Sci. Nutr. 38 (1998) 639-674.
88. K.-T. Lee, C. C. Akoh: Structured lipids: synthesis and applications. Food Rev. Int. 14 (1998) 17-34.
89. E. Ledochowaska: Enzymatic interesterfication of blends of liquid and totally hyrogenated fats to obtain the margarine base stocks of minimal content of trans isomers. Pol. J. Food Nutr. Sci. 8 (1999) 65-76.